Strong data from DSR® proof-of-concept studies in heart failure published in European Journal ...
Serial Direct Sodium Removal in Patients with Heart Failure and Diuretic Resistance
Stay updated with breaking news from Jeffrey Testani. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Serial Direct Sodium Removal in Patients with Heart Failure and Diuretic Resistance
Serial Direct Sodium Removal in Patients with Heart Failure and Diuretic Resistance Ghent, Belgium – 3 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today announces that the results from two proof-of-concept studies, RED DESERT and SAHARA, of the Company’s DSR therapy in patients with diuretic-resistant heart failure have been published in the prestigious pe
The complete list of late-breaking clinical science to be presented at THT 2024: Technology and Heart Failure Therapeutics is now available online. An internat
The complete list of late-breaking clinical science to be presented at THT 2024: Technology and Heart Failure Therapeutics is now available online. An internat
Presentation by Key Opinion Leader Dr. Testani on Wednesday, March 6th 2024Ghent, Belgium – 28 February 2024– Sequana Medical NV (Euronext Brussel...